SPCX Fades ~10% Post-Debut as CFRA's $115 Sell Splits the Street

The Day-Two Hangover

The SPCX perp is down 9.94% over 24 hours to $164.80, off from levels near $183 a day earlier — the listing-day premium bleeding out one session after the largest IPO on record. The equity priced at $135 and opened at $150 before closing up roughly 19% near $161 on Friday, briefly valuing SpaceX above $2.1 trillion, with after-hours and overnight perp trading reaching higher still before the reversal.

None of this is a thesis break. It's the mechanical digestion that follows a record debut: once the scramble for allocation clears, price has to be defended on fundamentals instead of scarcity, and a stock that ran 19% in a day on a no-earnings catalyst is the first place that pressure shows up.

A $75 Spread on Day One

The cleanest tell that this is a valuation fight and not a news event is how far apart the Street set up on the very first day. CFRA's Keith Snyder opened coverage with a rare Sell and a $115 target — roughly 15% below the $135 IPO price and about 23% under the $150 open. On the other side, Oppenheimer initiated at Outperform with a $190 target, implying around 40% upside from the IPO price and a roughly $2.5 trillion company.

That's a $75 spread on the same stock on the same morning, and Morningstar pegs fair value at well under half the IPO mark. When the bookend targets are that wide, there is no consensus to lean on — every tick down is just the market voting on which analyst it believes.

The Bear Case Under the Hood

CFRA isn't arguing SpaceX is a bad company; it's arguing the price already assumes near-flawless execution. The fundamentals leave little room for a miss: the Q1 2026 net loss ran $4.30 billion on $4.70 billion of revenue, the company lost roughly $8.7 billion across 2025 into early 2026 and carries an accumulated deficit near $41.3 billion.

Snyder's specific worry is concentration risk. Starship is a single execution bottleneck where delays ripple across nearly every growth line; Starlink ARPU is sliding as it pushes into lower-priced international markets; and the xAI and orbital-compute story is early and cash-hungry enough that he cautions against assigning it much value yet. At about 20x his 2027 sales estimate, a single slipped timeline is enough to break the math — which is exactly what a day-two fade starts to price.

What Cuts the Other Way

The bull rebuttal is structural: SPCX is the only liquid pure-play on the entire SpaceX stack — rockets, Starlink, and xAI under one ticker — and scarcity plus passive demand into a $1.77 trillion-cap name tends to find bids on dips. Oppenheimer's $190 leans on satellite connectivity and orbital AI data centers as the lines that justify the premium.

For perp traders there's an extra wrinkle worth respecting: the SPCX market tracks the value of a single Class A share, so the contract carries basis risk against the cash equity and can overshoot in both directions on a float this newly public and this thin. The fade invalidates the easy debut-momentum long. It does not settle the $115-versus-$190 argument — and that argument, not the next 24-hour candle, is the real position to have a view on.